907
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Chitosan nanoparticles as a potential nonviral gene delivery for HPV-16 E7 into mammalian cells

, , , , , & show all
Pages 366-372 | Received 03 Dec 2013, Accepted 09 Feb 2014, Published online: 19 Mar 2014

References

  • Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. 2004. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release. 100:5–28.
  • Akhlaghi SP, Saremi S, Ostad SN, Dinarvand R, Atyabi F. 2010. Discriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell lines. Nanomedicine. 6:689–697.
  • Atyabi F, Aghaei Moghaddam F, Dinarvand R, Zohuriaan-Mehrd MJ, Ponchele G.Thiolated chitosan coated poly hydroxyethyl methacrylatenanoparticles: synthesis and characterization. Carbohydr Polym. 2008;74:59–67.
  • Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 87:796–802.
  • Bozkir A, Saka OM. 2004. Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics. Drug Deliv. 11:107–112.
  • Chen CH, Wang TL, Hung CF, Yang Y, Young RA, Pardoll DM, Wu TC. 2000. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP-70 gene. Cancer Res. 60:1035.
  • Danielsen S. 2004. Structural analysis of chitosan mediated DNA condensation by AFM: influence of chitosan molecular parameters. Biomacromolecules. 5:928–936.
  • Duggan MA, McGregor SE, Stuart GC, Morris S, Chang-Poon V, Schepansky A, Honore L. 1998. The natural history of CIN I lesions. Eur J Gynaecol Oncol. 19:338–344.
  • Dutta A, Saxena K, Schwalbe H, Klein-Seetharaman J. 2012. Isotope labeling in mammalian cells. Methods Mol Biol. 831:55–69.
  • Ferber D. 2001. Gene therapy. Safer and virus-free? Science. 294: 1638–1642.
  • Ghaemi A, Soleimanjahi H, Gill P, Hassan Z, Jahromi SR, Roohvand F. 2010. Recombinant lambda-phage nanobioparticles for tumor therapy in mice models. Genet Vaccines Ther. 8:3.
  • Ghaemi A, Soleimanjahi H, Gill P, Hassan ZM, Razeghi S, Fazeli M, Razavinikoo SM. 2011. Protection of mice by a lambda-based therapeutic vaccine against cancer associated with human papillomavirus type 16. Intervirology.;54:105–112.
  • Hallaj-Nezhadi S, Valizadeh H, Dastmalchi S, Baradaran B, Jalali MB, Dobakhti F, Lotfipour F. 2011. Preparation of chitosan-plasmid DNA nanoparticles encoding interleukin-12 and their expression in CT-26 colon carcinoma cells. J Pharm Pharm Sci. 14:181–195.
  • Jayakumar R, Chennazhi KP, Muzzarelli RAA, Tamura H, Nair SV, Selvamurugan N. 2010. Chitosan conjugated DNA nanoparticles in gene therapy. Carbohydr Polym. 79:1–8.
  • Lavertu M, Méthot S, Tran-Khanh N, Buschmann MD. 2006. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials. 27:4815–4824.
  • Mao S, Sun W, Kissel T.Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev. 2010;62:12–27.
  • Melief CJ, Toes RE, Medema JP, van der Burg SH, Ossendorp F, Offringa R. 2000. Strategies for immunotherapy of cancer. Adv Immunol. 75:235–282.
  • Nahaei M, Valizadeh H, Baradaran B, Nahaei MR, Asgari D, Hallaj-Nezhadi S, et al. 2013. Preparation and characterization of chitosan/beta-cyclodextrin nanoparticles containing plasmid DNA encoding interleukin-12. Drug Res. 63:7–12.
  • Onishi H, Machida Y. 1999. Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials. 20:175–182.
  • Pouton CW, Seymour LW. 2001. Key issues in non-viral gene delivery. Adv Drug Deliv Rev. 46:187–203.
  • Rudzinski WE, Aminabhavib TM. 2010. Chitosan as a carrier for targeted delivery of small interfering RNA. Int J Pharm. 399:1–11.
  • Somia N, Verma IM. 2000. Gene therapy: trials and tribulations. Nat Rev Genet. 1:91–99.
  • Vila A, Sánchez A, Janes K, Behrens I, Kissel T, Vila Jato JL, Alonso MJ. 2004. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm. 57:123–131.
  • Vimal S, Abdul Majeed S, Taju G, Nambi KS, Sundar Raj N, Madan N, et al. 2013. Chitosan tripolyphosphate (CS/TPP) nanoparticles: Preparation, characterization and application for gene delivery in shrimp. Acta Trop. 128:486–493.
  • Weecharangsan W, Opanasopit P, Ngawhirunpat T, Apirakaramwong A, Rojanarata T, Ruktanonchai U, Lee RJ. 2008. Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells. Int J Pharm348:161–168.
  • Wu Y, Yang W, Wang C, Hu J, Fu S.Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int J Pharm. 2005;295:235–245.
  • Yousefpour P, Atyabi F, Dinarvand R, Vasheghani-Farahani E. 2011. Preparation and comparison of chitosan nanoparticles with different degrees of glutathione thiolation. Daru. 19:367–375.
  • Yuan Y, Tan J, Wang Y, Qian C, Zhang M. 2009. Chitosan nanoparticles as non-viral gene delivery vehicles based on atomic force microscopy study. Acta Biochim Biophys Sin. 41: 515–526.
  • zur Hausen H. 1996. Papillomavirus infections–a major cause of human cancers. Biochim Biophys Acta. 1288:F55–F78.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.